Artikel dengan mandat akses publik - Tobias KesslerPelajari lebih lanjut
Tidak tersedia di mana pun: 4
Glutamatergic synaptic input to glioma cells drives brain tumour progression
V Venkataramani, DI Tanev, C Strahle, A Studier-Fischer, L Fankhauser, ...
Nature 573 (7775), 532-538, 2019
Mandat: German Research Foundation, UK Medical Research Council, National Centre for …
Targeting resistance against the MDM2 inhibitor RG7388 in glioblastoma cells by the MEK inhibitor trametinib
A Berberich, T Kessler, CM Thomé, S Pusch, T Hielscher, F Sahm, ...
Clinical Cancer Research 25 (1), 253-265, 2019
Mandat: Helmholtz Association
Theme 06-Tissue Biomarkers.
A Wachinger, C Fuetterer, T Kessler, M Freigang, A Quinten, A Leinert, ...
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration 24, 2023
Mandat: National Natural Science Foundation of China
PL01. 4. A LATE BREAKING ABSTRACT: A LONG PEPTIDE VACCINE TARGETING THE CLONAL DRIVER MUTATION H3K27M IN ADULT PATIENTS WITH DIFFUSE MIDLINE GLIOMA
N Grassl, I Poschke, K Lindner, K Kromer, L Bunse, I Mildenberger, ...
Neuro-Oncology 25 (Supplement_2), ii1-ii1, 2023
Mandat: Canadian Institutes of Health Research
Tersedia di suatu tempat: 44
Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate
L Bunse, S Pusch, T Bunse, F Sahm, K Sanghvi, M Friedrich, D Alansary, ...
Nature medicine 24 (8), 1192-1203, 2018
Mandat: German Research Foundation, Helmholtz Association, European Commission …
Glioblastoma hijacks neuronal mechanisms for brain invasion
V Venkataramani, Y Yang, MC Schubert, E Reyhan, SK Tetzlaff, ...
Cell 185 (16), 2899-2917. e31, 2022
Mandat: German Research Foundation, European Commission
Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas
M Friedrich, R Sankowski, L Bunse, M Kilian, E Green, ...
Nature cancer 2 (7), 723-740, 2021
Mandat: German Research Foundation, Helmholtz Association, UK Medical Research …
Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data
G Thomalla, F Boutitie, H Ma, M Koga, P Ringleb, LH Schwamm, O Wu, ...
The Lancet 396 (10262), 1574-1584, 2020
Mandat: US National Institutes of Health, National Health and Medical Research …
Autonomous rhythmic activity in glioma networks drives brain tumour growth
D Hausmann, DC Hoffmann, V Venkataramani, E Jung, S Horschitz, ...
Nature 613 (7942), 179-186, 2023
Mandat: German Research Foundation, Federal Ministry of Education and Research, Germany
N2M2 (NOA-20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated …
W Wick, S Dettmer, A Berberich, T Kessler, I Karapanagiotou-Schenkel, ...
Neuro-oncology 21 (1), 95-105, 2019
Mandat: Helmholtz Association, Federal Ministry of Education and Research, Germany
Tumor cell plasticity, heterogeneity, and resistance in crucial microenvironmental niches in glioma
E Jung, M Osswald, M Ratliff, H Dogan, R Xie, S Weil, DC Hoffmann, ...
Nature communications 12 (1), 1014, 2021
Mandat: German Research Foundation
Deep-learning-based synthesis of post-contrast T1-weighted MRI for tumour response assessment in neuro-oncology: a multicentre, retrospective cohort study
CJ Preetha, H Meredig, G Brugnara, MA Mahmutoglu, M Foltyn, F Isensee, ...
The Lancet Digital Health 3 (12), e784-e794, 2021
Mandat: German Research Foundation
Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation
T Kessler, F Sahm, A Sadik, D Stichel, A Hertenstein, G Reifenberger, ...
Neuro-oncology 20 (3), 367-379, 2018
Mandat: Government of Spain
Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter methylated malignant astrocytoma
A Wick, T Kessler, M Platten, C Meisner, M Bamberg, U Herrlinger, ...
Neuro-oncology 22 (8), 1162-1172, 2020
Mandat: German Research Foundation
Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma
T Kessler, F Sahm, J Blaes, M Osswald, P Rübmann, D Milford, S Urban, ...
Oncotarget 6 (31), 31050, 2015
Mandat: German Research Foundation, European Commission
Cerebrospinal fluid proteomic profiling in nusinersen‐treated patients with spinal muscular atrophy
T Kessler, P Latzer, D Schmid, U Warnken, A Saffari, A Ziegler, J Kollmer, ...
Journal of neurochemistry 153 (5), 650-661, 2020
Mandat: Federal Ministry of Education and Research, Germany
A H3K27M-targeted vaccine in adults with diffuse midline glioma
N Grassl, I Poschke, K Lindner, L Bunse, I Mildenberger, T Boschert, ...
Nature Medicine 29 (10), 2586-2592, 2023
Mandat: German Research Foundation, Helmholtz Association
Oligosarcomas, IDH-mutant are distinct and aggressive
AK Suwala, M Felix, D Friedel, D Stichel, D Schrimpf, F Hinz, E Hewer, ...
Acta neuropathologica 143 (2), 263-281, 2022
Mandat: German Research Foundation, Federal Ministry of Education and Research, Germany
Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation—the NCT Neuro Master Match (N2M2) pilot study
E Pfaff, T Kessler, GP Balasubramanian, A Berberich, D Schrimpf, A Wick, ...
Neuro-oncology 20 (6), 826-837, 2018
Mandat: Helmholtz Association
Tumor cell network integration in glioma represents a stemness feature
R Xie, T Kessler, J Grosch, L Hai, V Venkataramani, L Huang, ...
Neuro-oncology 23 (5), 757-769, 2021
Mandat: German Research Foundation, Helmholtz Association
Informasi terbitan dan pendanaan ditentukan secara otomatis oleh program komputer